Home » Regeneron Closes $312 Million Common Stock Sale
Regeneron Closes $312 Million Common Stock Sale
Regeneron Pharmaceuticals, Inc. announced that following early termination of the Hart-Scott-Rodino waiting period, the company closed the sale of 12 million newly issued shares of Regeneron common stock to the sanofi-aventis Group at a price of $26.00 per share pursuant to its previously announced agreement.
Fox Business
Fox Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May